ABBOTT LABORATORIES — Director's Dealing 2014

Feb 25, 2014

Page 1 of 1

SEC FORM 4

SEC Form 4

==> picture [490 x 270] intentionally omitted <==

----- Start of picture text ----- FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION OMB APPROVALWashington, D.C. 20549OMB Number: 3235-0287Check this box if no longer subject to STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Expires: December 31, 2014Section 16. Form 4 or Form 5 Estimated average burdenobligations may continue. Instruction 1(b). See Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934or Section 30(h) of the Investment Company Act of 1940 hours per response: 0.51. Name and Address of Reporting Person [*] 2. Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to IssuerFoltz Charles D ABBOTT LABORATORIES [ ABT ] (Check all applicable)Director 10% OwnerX Officer (give title Other (specify3. Date of Earliest Transaction (Month/Day/Year) below) below)(Last) (First) (Middle)02/21/2014 Senior Vice President100 ABBOTT PARK ROAD4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable(Street) Line)ABBOTT X Form filed by One Reporting PersonIL 60064PARK Form filed by More than One ReportingPerson(City) (State) (Zip)Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned1. Title of Security (Instr. 3) 2. Transaction 2A. Deemed 3. 4. Securities Acquired (A) 5. Amount of 6. 7. NatureDate Execution Date, Transaction or Disposed Of (D) (Instr. Securities Ownership of Indirect(Month/Day/Year) if any Code (Instr. 3, 4 and 5) Beneficially Form: Direct Beneficial(Month/Day/Year) 8) Owned (D) or OwnershipFollowing Indirect (I) (Instr. 4)(A) Reported (Instr. 4)Code V Amount or Price Transaction(s)(D) (Instr. 3 and 4)Common shares without par value 02/21/2014 A 16,730(1) A $ 0 70,992 D----- End of picture text -----

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1. Title of	2.	3. Transaction	3A. Deemed	4.		5. Number of	6. Date Exercisable and	6. Date Exercisable and	7. Title and	Amount	8. Price of	9. Number	10.	11. Nature
Derivative	Conversion	Date	Execution Date,	Transaction		Derivative	Expiration Date		of Securities		Derivative	of	Ownership	of Indirect
Security	or Exercise	(Month/Day/Year)	if any	Code	(Instr.	Securities	(Month/Day/Year)		Underlying		Security	derivative	Form:	Beneficial
(Instr. 3)	Price of		(Month/Day/Year)	8)		Acquired (A)			Derivative Security		(Instr. 5)	Securities	Direct (D)	Ownership
	Derivative					or Disposed			(Instr. 3 and 4)			Beneficially	or Indirect	(Instr. 4)
	Security					of (D) (Instr.						Owned	(I) (Instr. 4)
						3, 4 and 5)						Following
												Reported
										Amount		Transaction
										or		(s) (Instr. 4)
							Date	Expiration		Number
				Code	V	(A)(D)	Exercisable	Date	Title	of Shares
Option(right tobuy) (2)	$39.12	02/21/2014		A		102,425	02/21/2015	02/20/2024	Commonshares	102,425	$0	102,425	D

Explanation of Responses:

1. These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

2. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 34,142 on 2/21/2015, 34,141 on 2/21/2016, and 34,142 on 2/21/2017.

John A. Berry, by Power of 02/25/2014 Attorney for Charles D. Foltz

• ** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

• ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

2/25/2014